Management of gabapentin misuse in a patient with previous history of opioid use disorder: Case report

被引:2
作者
Khave, Laya Jalilian [1 ,2 ]
Noori, Mehri [3 ]
Rahimi-Movaghar, Afarin [3 ]
Noroozi, Alireza [3 ,4 ]
机构
[1] Yale Sch Med, Dept Psychiat, New Haven, CT USA
[2] Shahid Beheshti Univ Med Sci, Fac Med, Tehran, Iran
[3] Univ Tehran Med Sci, Iranian Natl Ctr Addict Studies, Tehran, Iran
[4] Iranian Natl Ctr Addict Studies, 486, South Kargar St, Tehran, Iran
关键词
Gabapentin; Substance use disorder; Case report; ABUSE; DEPENDENCE; PREGABALIN; SYMPTOMS;
D O I
10.1016/j.ajp.2022.103322
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
We present a 37-year-old male who misuses 12 g of gabapentin per day associated with dependence and withdrawal. He had a previous history of opioid use disorder (OUD) which has been in remission. An outpatient gradual dose reduction regimen was tried and failed and the patient decided to discontinue gabapentin abruptly. Symptomatic medication to relieve gabapentin withdrawal was also unsuccessful and resulted in the reinstatement of OUD. Finally, the patient was stabilized using buprenorphine maintenance treatment and discontinued opioids and gabapentin misuse. The clinical implications and significance of taking regulatory actions to control gabapentin misuse have been discussed.
引用
收藏
页数:4
相关论文
共 31 条
[1]   Abuse liability of gabapentin in the Saudi population after the pregabalin restriction: A cross-sectional study [J].
Alkhalaf, Amina A. ;
Bukhari, Raneem A. ;
Alshehri, Elham A. ;
Alshehri, Samah O. ;
Badr, Aisha F. .
JOURNAL OF TAIBAH UNIVERSITY MEDICAL SCIENCES, 2021, 16 (05) :700-705
[2]   A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and Gabapentin [J].
Bockbrader, Howard N. ;
Wesche, David ;
Miller, Raymond ;
Chapel, Sunny ;
Janiczek, Nancy ;
Burger, Paula .
CLINICAL PHARMACOKINETICS, 2010, 49 (10) :661-669
[3]   How addictive are gabapentin and pregabalin? A systematic review [J].
Bonnet, U. ;
Scherbaum, N. .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 (12) :1185-1215
[4]   Earlier discovery of pregabalin's dependence potential might have been possible [J].
Caster, Ola ;
Edwards, I. Ralph ;
Noren, G. Niklas ;
Lindquist, Marie .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 67 (03) :319-320
[5]   Gabapentinoids: pharmacokinetics, pharmacodynamics and considerations for clinical practice [J].
Chincholkar, Mahindra .
BRITISH JOURNAL OF PAIN, 2020, 14 (02) :104-114
[6]   Gabapentin dependence and withdrawal requiring an 18-month taper in a patient with alcohol use disorder: a case report [J].
Deng, Huiqiong ;
Benhamou, Ori-Michael ;
Lembke, Anna .
JOURNAL OF ADDICTIVE DISEASES, 2021, 39 (04) :575-578
[7]   Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update [J].
Evoy, Kirk E. ;
Sadrameli, Sarvnaz ;
Contreras, Jillian ;
Covvey, Jordan R. ;
Peckham, Alyssa M. ;
Morrison, Megan D. .
DRUGS, 2021, 81 (01) :125-156
[8]  
France 24, 2021, PRIC SOAR OP MARK TA
[9]   A Clinical Overview of Off-label Use of Gabapentinoid Drugs [J].
Goodman, Christopher W. ;
Brett, Allan S. .
JAMA INTERNAL MEDICINE, 2019, 179 (05) :695-701
[10]   Withdrawal symptoms after gabapentin discontinuation [J].
Hellwig, Thaddaus R. ;
Hammerquist, Rhonda ;
Termaat, Jill .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (11) :910-912